Brief: Oasmia’s Partner Signs Licensing Deal For Commercialization Of Apealea in Europe

Vivesto AB

28/12/2020 06:03

Dec 28 (Reuters) - Oasmia Pharmaceutical AB  OASM.ST :
    * OASMIA’S PARTNER ELEVAR THERAPEUTICS SIGNS LICENSING
AGREEMENT
WITH INCEPTUA GROUP FOR THE COMMERCIALIZATION OF APEALEA®
(PACLITAXEL MICELLAR) IN EUROPE
    * UNDER TERMS OF AGREEMENT, INCEPTUA WILL HAVE EXCLUSIVE
RIGHTS TO
DISTRIBUTE AND COMMERCIALIZE APEALEA IN EUROPE, EXCLUDING NORDIC
COUNTRIES

Source text for Eikon:  ID:nMFN7Msv2Q 
Further company coverage:  OASM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))